Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

v3.6.0.2
Segment reporting (Tables)
6 Months Ended
Jan. 31, 2017
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] The following financial information represents the operating results of the reportable segments of the Company:

Three months ended January 31, 2017   Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 18,837                       $ 18,837  
Product revenues         $ 6,983                   6,983  
Royalty and license fee income           440                   440  
      18,837       7,423                   26,260  
Operating costs, expenses and legal settlements, net:                                        
Cost of clinical laboratory services     11,052                         11,052  
Cost of product revenues           3,520                   3,520  
Research and development           516     $ (33 )           483  
Selling, general and administrative     5,897       2,905           $ 2,363       11,165  
Provision for uncollectible accounts receivable     594       85                   679  
Legal fee expense     49       16             305       370  
Total operating costs, expenses and legal settlements, net     17,592       7,042       (33 )     2,668       27,269  
                                         
Operating income (loss)     1,245       381       33       (2,668 )     (1,009 )
                                         
Other income (expense):                                        
Interest     (28 )     12             95       79  
Other     17                   7       24  
Foreign exchange loss           (94 )                 (94 )
Income (loss) before income taxes   $ 1,234     $ 299     $ 33     $ (2,566 )   $ (1,000 )
                                         
Depreciation and amortization included above   $ 394     $ 501     $     $ 20     $ 915  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 1                       $ 1  
Selling, general and administrative     23     $ 15           $ 202       240  
Total   $ 24     $ 15     $     $ 202     $ 241  
                                         
Capital expenditures   $ 175     $     $     $     $ 175  
Three months ended January 31, 2016   Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 17,523                       $ 17,523  
Product revenues         $ 6,578                   6,578  
Royalty and license fee income           459                   459  
      17,523       7,037                   24,560  
Operating costs, expenses and legal settlements, net:                                        
Cost of clinical laboratory services     10,535                         10,535  
Cost of product revenues           3,206                   3,206  
Research and development           661     $ 200             861  
Selling, general and administrative     5,649       2,773           $ 2,858       11,280  
Provision for uncollectible accounts receivable     467       (8 )                 459  
Legal fee expense     57       5             2,349       2,411  
Legal settlements, net     1,500       (13,150 )                 (11,650 )
Total operating costs, expenses and legal settlements, net     18,208       (6,513 )     200       5,207       17,102  
                                         
Operating income (loss)     (685 )     13,550       (200 )     (5,207 )     7,458  
                                         
Other income (expense)                                        
Interest     (23 )     17             (36 )     (42 )
Other     (1 )                 12       11  
Foreign exchange loss           (388 )                 (388 )
Income (loss) before income taxes   $ (709 )   $ 13,179     $ (200 )   $ (5,231 )   $ 7,039  
                                         
Depreciation and amortization included above   $ 411     $ 524     $     $ 17     $ 952  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 2                       $ 2  
Selling, general and administrative     9     $ 5           $ 94       108  
Total   $ 11     $ 5     $     $ 94     $ 110  
                                         
Capital expenditures   $ 354     $ 84     $     $     $ 438  
Six months ended January 31, 2017   Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 37,395                       $ 37,395  
Product revenues         $ 14,409                   14,409  
Royalty and license fee income           740                   740  
      37,395       15,149                   52,544  
Operating costs, expenses and legal settlements, net:                                        
Cost of clinical laboratory services     21,948                         21,948  
Cost of product revenues           6,829                   6,829  
Research and development           1,143     $ 162             1,305  
Selling, general and administrative     11,849       5,851           $ 4,939       22,639  
Provision for uncollectible accounts receivable     1,260       88                   1,348  
Legal fee expense     101       28             613       742  
Total operating costs, expenses and legal settlements, net     35,158       13,939       162       5,552       54,811  
                                         
Operating income (loss)     2,237       1,210       (162 )     (5,552 )     (2,267 )
                                         
Other income (expense):                                        
Interest     (57 )     22             160       125  
Other     119                   24       143  
Foreign exchange loss           (455 )                 (455 )
Income (loss) before income taxes   $ 2,299     $ 777     $ (162 )   $ (5,368 )   $ (2,454 )
                                         
Depreciation and amortization included above   $ 795     $ 1,009     $     $ 38     $ 1,842  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 3                       $ 3  
Selling, general and administrative     40     $ 26           $ 323       389  
Total   $ 43     $ 26     $     $ 323     $ 392  
                                         
Capital expenditures   $ 587     $ 102     $     $     $ 689  
Six months ended January 31, 2016   Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 34,613                       $ 34,613  
Product revenues         $ 14,265                   14,265  
Royalty and license fee income           859                   859  
      34,613       15,124                   49,737  
Operating costs, expenses and legal settlements, net:                                        
Cost of clinical laboratory services     20,867                         20,867  
Cost of product revenues           6,817                   6,817  
Research and development           1,328     $ 400             1,728  
Selling, general and administrative     10,935       5,832           $ 4,738       21,505  
Provision for uncollectible accounts receivable     1,175       (12 )                 1,163  
Legal fee expense     66       (17 )           3,963       4,012  
Legal settlements, net     1,500       (19,950 )                 (18,450 )
Total operating costs, expenses and legal settlements, net     34,543       (6,002 )     400       8,701       37,642  
                                         
Operating income (loss)     70       21,126       (400 )     (8,701 )     12,095  
                                         
Other income (expense)                                        
Interest     (42 )     31             (71 )     (82 )
Other     3       39             23       65  
Foreign exchange loss           (518 )                 (518 )
Income (loss) before income taxes   $ 31     $ 20,678     $ (400 )   $ (8,749 )   $ 11,560  
                                         
Depreciation and amortization included above   $ 808     $ 1,054     $     $ 40     $ 1,902  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 3                       $ 3  
Selling, general and administrative     19     $ 10           $ 189       218  
Total   $ 22     $ 10     $     $ 189     $ 221  
                                         
Capital expenditures   $ 791     $ 152     $     $     $ 943